VN D301Alternative Names: VN-D301
Latest Information Update: 10 Feb 2017
At a glance
- Originator VitNovo
- Mechanism of Action Diagnostic imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 07 Feb 2017 Early research in Undefined indication (Diagnosis) in Taiwan (unspecified route)
- 07 Feb 2017 Early research in Undefined indication in Taiwan (unspecified route)